137 related articles for article (PubMed ID: 3119181)
1. A rostrocaudal gradient for aromatic acid decarboxylase in the human striatum.
Garnett ES; Lang AE; Chirakal R; Firnau G; Nahmias C
Can J Neurol Sci; 1987 Aug; 14(3 Suppl):444-7. PubMed ID: 3119181
[TBL] [Abstract][Full Text] [Related]
2. Long-term restoration of striatal L-aromatic amino acid decarboxylase activity using recombinant adeno-associated viral vector gene transfer in a rodent model of Parkinson's disease.
Leff SE; Spratt SK; Snyder RO; Mandel RJ
Neuroscience; 1999; 92(1):185-96. PubMed ID: 10392841
[TBL] [Abstract][Full Text] [Related]
3. Depletion of AADC activity in caudate nucleus and putamen of Parkinson's disease patients; implications for ongoing AAV2-AADC gene therapy trial.
Ciesielska A; Samaranch L; San Sebastian W; Dickson DW; Goldman S; Forsayeth J; Bankiewicz KS
PLoS One; 2017; 12(2):e0169965. PubMed ID: 28166239
[TBL] [Abstract][Full Text] [Related]
4. Nigrostriatal reduction of aromatic L-amino acid decarboxylase activity in MPTP-treated squirrel monkeys: in vivo and in vitro investigations.
Yee RE; Huang SC; Stout DB; Irwin I; Shoghi-Jadid K; Togaski DM; DeLanney LE; Langston JW; Satyamurthy N; Farahani KF; Phelps ME; Barrio JR
J Neurochem; 2000 Mar; 74(3):1147-57. PubMed ID: 10693947
[TBL] [Abstract][Full Text] [Related]
5. A probe for intracerebral aromatic amino-acid decarboxylase activity: distribution and kinetics of [18F]6-fluoro-L-m-tyrosine in the human brain.
Nahmias C; Wahl L; Chirakal R; Firnau G; Garnett ES
Mov Disord; 1995 May; 10(3):298-304. PubMed ID: 7651447
[TBL] [Abstract][Full Text] [Related]
6. Complementary positron emission tomographic studies of the striatal dopaminergic system in Parkinson's disease.
Antonini A; Vontobel P; Psylla M; Günther I; Maguire PR; Missimer J; Leenders KL
Arch Neurol; 1995 Dec; 52(12):1183-90. PubMed ID: 7492293
[TBL] [Abstract][Full Text] [Related]
7. Dopa-decarboxylation in the striata of rats with unilateral substantia nigra lesions.
Kang UJ; Park DH; Wessel T; Baker H; Joh TH
Neurosci Lett; 1992 Nov; 147(1):53-7. PubMed ID: 1480324
[TBL] [Abstract][Full Text] [Related]
8. Aromatic L-amino acid decarboxylase in rat corpus striatum: implications for action of L-dopa in parkinsonism.
Melamed E; Hefti F; Pettibone DJ; Liebman J; Wurtman RJ
Neurology; 1981 Jun; 31(6):651-5. PubMed ID: 7195482
[TBL] [Abstract][Full Text] [Related]
9. Striatal L-dopa decarboxylase activity in Parkinson's disease in vivo: implications for the regulation of dopamine synthesis.
Gjedde A; Léger GC; Cumming P; Yasuhara Y; Evans AC; Guttman M; Kuwabara H
J Neurochem; 1993 Oct; 61(4):1538-41. PubMed ID: 8377003
[TBL] [Abstract][Full Text] [Related]
10. Localization and functional significance of striatal neurons immunoreactive to aromatic L-amino acid decarboxylase or tyrosine hydroxylase in rat Parkinsonian models.
Lopez-Real A; Rodriguez-Pallares J; Guerra MJ; Labandeira-Garcia JL
Brain Res; 2003 Apr; 969(1-2):135-46. PubMed ID: 12676374
[TBL] [Abstract][Full Text] [Related]
11. Comparative assessment of 6-[
Becker G; Bahri MA; Michel A; Hustadt F; Garraux G; Luxen A; Lemaire C; Plenevaux A
J Neurochem; 2017 May; 141(4):626-635. PubMed ID: 28294334
[TBL] [Abstract][Full Text] [Related]
12. The localization and functional contribution of striatal aromatic L-amino acid decarboxylase to L-3,4-dihydroxyphenylalanine decarboxylation in rodent parkinsonian models.
Nakamura K; Ahmed M; Barr E; Leiden JM; Kang UJ
Cell Transplant; 2000; 9(5):567-76. PubMed ID: 11144954
[TBL] [Abstract][Full Text] [Related]
13. Striatal 3,4-dihydroxyphenylalanine decarboxylase in aging: disparity between postmortem and positron emission tomography studies?
Kish SJ; Zhong XH; Hornykiewicz O; Haycock JW
Ann Neurol; 1995 Aug; 38(2):260-4. PubMed ID: 7654075
[TBL] [Abstract][Full Text] [Related]
14. Aromatic L-amino acid decarboxylase modulation and Parkinson's disease.
Neff NH; Hadjiconstantinou M
Prog Brain Res; 1995; 106():91-7. PubMed ID: 8584678
[TBL] [Abstract][Full Text] [Related]
15. Noninvasive assessment of aromatic L-amino acid decarboxylase activity in aging rhesus monkey brain in vivo.
Dejesus OT; Endres CJ; Shelton SE; Nickles RJ; Holden JE
Synapse; 2001 Jan; 39(1):58-63. PubMed ID: 11071710
[TBL] [Abstract][Full Text] [Related]
16. Aromatic L-amino acid decarboxylase immunoreactive cells in the rat striatum: a possible site for the conversion of exogenous L-DOPA to dopamine.
Mura A; Jackson D; Manley MS; Young SJ; Groves PM
Brain Res; 1995 Dec; 704(1):51-60. PubMed ID: 8750961
[TBL] [Abstract][Full Text] [Related]
17. Effects of benserazide on L-DOPA-derived extracellular dopamine levels and aromatic L-amino acid decarboxylase activity in the striatum of 6-hydroxydopamine-lesioned rats.
Shen H; Kannari K; Yamato H; Arai A; Matsunaga M
Tohoku J Exp Med; 2003 Mar; 199(3):149-59. PubMed ID: 12703659
[TBL] [Abstract][Full Text] [Related]
18. Adeno-associated virus-mediated gene transfer of human aromatic L-amino acid decarboxylase protects mixed striatal primary cultures from L-DOPA toxicity.
Doroudchi MM; Liauw J; Heaton K; Zhen Z; Forsayeth JR
J Neurochem; 2005 May; 93(3):634-40. PubMed ID: 15836622
[TBL] [Abstract][Full Text] [Related]
19. [Expression and assessment of double genes of tyrosine hydroxylase gene and aromatic L-amino acid decarboxylase gene in vitro].
Su Y; Duan CL; Zhao CL; Zhao HY; Xu QY; Yang H
Sheng Li Xue Bao; 2003 Oct; 55(5):583-8. PubMed ID: 14566408
[TBL] [Abstract][Full Text] [Related]
20. Subregional 6-[18F]fluoro-ʟ-m-tyrosine uptake in the striatum in Parkinson's disease.
Asari S; Fujimoto K; Miyauchi A; Sato T; Nakano I; Muramatsu S
BMC Neurol; 2011 Mar; 11():35. PubMed ID: 21429212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
